Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.57B | 973.00M | 251.00M | -1.12B | 837.00M | -173.00M |
Gross Profit | 584.00M | 973.00M | 251.00M | 2.48B | 749.00M | -439.00M |
EBITDA | 2.60B | 3.92B | 2.59B | 2.40B | 749.00M | 0.00 |
Net Income | 470.00M | 863.00M | 155.00M | -1.19B | 749.00M | -266.00M |
Balance Sheet | ||||||
Total Assets | 95.89B | 88.02B | 71.60B | 51.75B | 68.15B | 81.82B |
Cash, Cash Equivalents and Short-Term Investments | 1.72B | 505.00M | 518.00M | 1.02B | 998.00M | 1.02B |
Total Debt | 83.38B | 64.00M | 80.00M | 95.00M | 126.00M | 177.00M |
Total Liabilities | 85.85B | 78.25B | 63.34B | 43.88B | 57.86B | 70.74B |
Stockholders Equity | 10.04B | 9.76B | 8.26B | 7.87B | 10.29B | 11.08B |
Cash Flow | ||||||
Free Cash Flow | 258.00M | 86.00M | -118.00M | 1.01B | 1.54B | 1.75B |
Operating Cash Flow | 258.00M | 86.00M | -118.00M | 1.01B | 1.54B | 1.75B |
Investing Cash Flow | -17.48B | -11.17B | -14.67B | 11.19B | 3.84B | 36.52B |
Financing Cash Flow | 17.07B | 11.08B | 14.23B | -11.39B | -6.17B | -37.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $2.16B | 11.37 | 7.77% | 10.67% | -15.99% | -36.34% | |
69 Neutral | $7.09B | 21.97 | 4.90% | 9.19% | -15.62% | -31.74% | |
68 Neutral | $6.19B | 9.75 | 9.36% | 8.56% | 26.78% | -19.34% | |
66 Neutral | $9.59B | 24.01 | 5.05% | 15.32% | -2.35% | -56.25% | |
66 Neutral | £947.02M | 13.94 | 2.04% | 5.24% | 11.04% | 38.13% | |
63 Neutral | $3.42B | ― | -2.06% | 9.44% | -20.46% | -1436.71% | |
62 Neutral | $11.93B | 22.41 | 5.44% | 14.20% | 2.32% | ― |